A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Clinical trial NCT01146574 · COMPLETED
Trial details
- NCT number
- NCT01146574
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-30
- Primary completion
- 2016-03-07
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.